Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Veracyte Inc (NASDAQ: VCYT) closed at $29.55 down -2.44% from its previous closing price of $30.29. In other words, the price has decreased by -$2.44 from its previous closing price. On the day, 0.9 million shares were traded. VCYT stock price reached its highest trading level at $30.355 during the session, while it also had its lowest trading level at $29.15.
Ratios:
For a deeper understanding of Veracyte Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 56.56. For the most recent quarter (mrq), Quick Ratio is recorded 4.17 and its Current Ratio is at 4.44. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 23, 2024, Reiterated its Buy rating but revised its target price to $33 from $30 previously.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 04 ’24 when JOHN LEITE bought 5,479 shares for $30.29 per share.
JONES EVAN/ FA sold 27,188 shares of VCYT for $875,565 on Aug 13 ’24. The Director now owns 5,173 shares after completing the transaction at $32.20 per share. On Aug 13 ’24, another insider, JONES EVAN/ FA, who serves as the Director of the company, sold 20,457 shares for $32.20 each. As a result, the insider received 658,801 and left with 34,343 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 2269797376 and an Enterprise Value of 2111562240. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.68 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 5.284 whereas that against EBITDA is 65.611.
Stock Price History:
Over the past 52 weeks, VCYT has reached a high of $33.33, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is 13.87%, while the 200-Day Moving Average is calculated to be 22.53%.
Shares Statistics:
For the past three months, VCYT has traded an average of 933.88K shares per day and 631290 over the past ten days. A total of 76.81M shares are outstanding, with a floating share count of 75.65M. Insiders hold about 1.51% of the company’s shares, while institutions hold 103.39% stake in the company. Shares short for VCYT as of 1723680000 were 3109757 with a Short Ratio of 3.33, compared to 1721001600 on 3121859. Therefore, it implies a Short% of Shares Outstanding of 3109757 and a Short% of Float of 4.52.
